Stephens & Co. Maintains Overweight on Guardian Pharmacy Service, Raises Price Target to $36
Benzinga Newsdesk 9 months ago
NewsPrice TargetAnalyst Ratings
Stephens & Co. analyst Scott Fidel maintains Guardian Pharmacy Service (NYSE:GRDN) with a Overweight and raises the price target from $35 to $36.
Stephens & Co. analyst Scott Fidel maintains Guardian Pharmacy Service (NYSE:GRDN) with a Overweight and raises the price target from $35 to $36.